Literature DB >> 2830965

Effects of bombesin on growth of human small cell lung carcinoma in vivo.

R W Alexander1, J R Upp, G J Poston, V Gupta, C M Townsend, J C Thompson.   

Abstract

Bombesin-like peptides are found in many different human tumors and are thought to function as an autocrine growth factor for small cell lung cancer in humans. In this study, a human small cell lung carcinoma (NCI-H69) was s.c. implanted bilaterally into the flanks of 12 nude mice. The mice were randomized and divided into two groups and given either bombesin (20 micrograms/kg) or saline i.p. 3 times a day. Tumor areas were measured twice weekly for 6 wk. At sacrifice, the tumors and normal pancreas were excised, weighed, and assayed for DNA, RNA, and protein content. Significant stimulation of tumor growth was observed at weeks 4, 5, and 6. Tumor weight at sacrifice was significantly elevated (77%) above the control, as was DNA content (78%). Bombesin significantly increased the weight (42%), DNA (48%), and protein (61%) contents of the normal mouse pancreas. We conclude that bombesin may act as an autocrine growth factor, or indirectly through the release of other growth factors, on human small cell lung carcinoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2830965

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.

Authors:  Pritha Paul; Lauren A Gillory; JungHee Kang; Jingbo Qiao; Dai H Chung
Journal:  Surgery       Date:  2010-10-29       Impact factor: 3.982

2.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

Review 3.  New perspectives in lung cancer. 2. Growth factors and lung cancer.

Authors:  P J Woll
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

Review 4.  Nuclear imaging of molecular processes in cancer.

Authors:  Rafael Torres Martin de Rosales; Erik Arstad; Philip J Blower
Journal:  Target Oncol       Date:  2009-09-25       Impact factor: 4.493

5.  Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

Authors:  A Nagy; P Armatis; R Z Cai; K Szepeshazi; G Halmos; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Gastrin-releasing peptide in human nasal mucosa.

Authors:  J N Baraniuk; J D Lundgren; J Goff; D Peden; M Merida; J Shelhamer; M Kaliner
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 7.  Somatostatin and analogues in the treatment of cancer. A review.

Authors:  B M Evers; D Parekh; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

8.  Gastrin-releasing peptide is a growth factor for human neuroblastomas.

Authors:  Sunghoon Kim; Wanqin Hu; David R Kelly; Mark R Hellmich; B Mark Evers; Dai H Chung
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

9.  Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines.

Authors:  J Staley; D H Coy; R T Jensen; T W Moody
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

10.  Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma.

Authors:  Jingbo Qiao; Junghee Kang; Titilope A Ishola; Piotr G Rychahou; B Mark Evers; Dai H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.